{"name":"Hopewell Therapeutics, Inc","round":{"amountQuarantined":false,"amountUsd":8007235,"connectionsAmong":[{"a":"p/qiaobing-xu","b":"p/thomas-v-hennessey-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"}],"since":null,"type":"board","via":"c/hopewell-tx-com"},{"a":"p/qiaobing-xu","b":"p/thomas-v-hennessey-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"}],"since":"2021-10-08","type":"worked_with","via":"c/hopewell-tx-com"}],"currency":"USD","date":"2021-09-24","investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"},"name":"Qiaobing Xu","role":"director","roleAsStated":"Director","slug":"qiaobing-xu"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"},"name":"Qiaobing Xu","role":"executive","roleAsStated":"Executive Officer","slug":"qiaobing-xu"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"},"name":"Thomas V. Hennessey","role":"director","roleAsStated":"Director","slug":"thomas-v-hennessey-2"}],"slug":"hopewell-tx-com-2021-09-24-round-0001836562-21-000002","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656221000002/primary_doc.xml"},"slug":"hopewell-tx-com"}